期刊文献+

宫颈上皮内瘤变的进展预警 被引量:16

Prediction of the Progress of Cervical Intraepithelial Neoplasia
下载PDF
导出
摘要 宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)是宫颈浸润癌的癌前病变。CIN的发生和进展是一个多因素、多水平的过程。大量研究证实高危型人乳头瘤病毒(human papillomavirus,HPV)持续感染是宫颈癌及CIN的重要致病原因之一,其与宫颈癌的发生、发展有着密切的关系。随着分子生物学的发展和测序技术的进步,阴道微生物与HPV在CIN和宫颈癌的协同作用逐渐被认识。而寻找和探索对CIN进展有判断价值的生物标志物,预警CIN的进展已经成为目前宫颈病变研究的一大热点。综述与CIN进展有关的原因、影响因素及标志物等,以期预警CIN的进展,正确分流及规范管理CIN。 Cervical intraepithelial neoplasia(CIN) is a precursor lesion for cervical cancer. The occurrence and progression of CIN is a multi-factor, multi-level process. Numerous studies have confirmed that high-risk HPV persistent infection is an important tumorigenesis cause of CIN and cervical cancer and is closely associated with the development of cervical cancer. With advances in molecular biology and the development of sequencing technology, the association of low genital tract microbiota with human papillomavirus(HPV) in the development of cervical intraepithelial neoplasia and cervical cancer is gradually being recognized. It has become a popular study to find and explore the prognostic biomarkers of CIN to predict the progression of CIN. This paper reviews the etiology, the influencing factors, and the markers associated with the progression of CIN, in order to properly predict the development of CIN, regulate the diversion and cervical intraepithelial management.
作者 蒋燕明 李力
出处 《国际妇产科学杂志》 CAS 2018年第1期71-75,共5页 Journal of International Obstetrics and Gynecology
基金 国家卫计委公益性行业科研专项(201402010)
关键词 宫颈上皮内瘤样病变 乳头状瘤病毒科 生物学标记 宫颈肿瘤 Cervical intraepithelial neoplasia Papillomaviridae Biological markers Uterine cervical neoplasms
  • 相关文献

参考文献2

二级参考文献31

  • 1刘畅,郭晓奎.乳酸菌基因组学研究进展[J].中国微生态学杂志,2006,18(4):328-330. 被引量:5
  • 2Lu B,Kumar A,Castellsague X,et al. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women:a systematic review & meta-analysis [J]. BMC Infect Dis,2011,11 : 13.
  • 3Schiffman M,Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer[J]. Cancer Epidemiol Biomarkers Prev, 2013,22(4) : 553-560.
  • 4Faridi R,Zahra A,Khan K,et al. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer[J]. Virol J,2011,8:269.
  • 5Deligeoroglou E, Giannouli A,Athanasopoulos N,et al. HPV infection: immunological aspects and their utility in future therapy [J]. Infect Dis Obstet Gynecol, 2013,2013 : 540850.
  • 6Wang JW, Roden RB. Virus-like particles for the prevention of human papillomavirus-associated malignancies [J]. Expert Rev Vaccines, 2013,12(2): 129-141.
  • 7Erickson BK,Alvarez RD,Huh WK. Human papillomavirus:what every provider should know[J]. Am J Obstet Gynecol, 2013,208 (3): 169-175.
  • 8Pang CL,Thierry F. Human papillomavirus proteins as prospective therapeutic targets[J]. Microb Pathog,2013,58:55-65.
  • 9Barrios K,Celis E. TriVax-HPV:an improved peptide-based therapeutic vaccination strategy against human papillomavirus- induced cancers [J]. Cancer Immunol Immunother,2012,61 (8): 1307-1317.
  • 10Jin XW,Lipold L,Sikon A,et al. Human papillomavirus vaccine: safe, effective, underused[J]. Cleve Clin J Med, 2013,80 ( 1 ) : 49-60.

共引文献49

同被引文献138

引证文献16

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部